N-Acetylcysteine in Idiopathic Pulmonary Fibrosis.1

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Acetylcysteine in Patients with Idiopathic Pulmonary Fibrosis with Background Treatment of Pirfenidone

• IRAS ID

  128259

• Contact name

  Toby Maher

• Contact email

  t.maher@ucl.ac.uk

• Sponsor organisation

  InterMune International AG.

• Eudract number

  2012-000564-14

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0231

• Date of REC Opinion

  11 Sep 2013

• REC opinion

  Further Information Favourable Opinion